Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
37
UHAL Quote, Financials, Valuation and Earnings
Last price:
$62.44
Seasonality move
:
10.14%
Day range:
$61.44 - $62.73
52-week range:
$56.28 - $79.04
Dividend yield:
0%
P/E ratio:
36.74x
P/S ratio:
2.10x
P/B ratio:
1.57x
Volume:
169.8K
Avg. volume:
160.5K
1-year change:
-5.82%
Market cap:
$11.8B
Revenue:
$5.8B
EPS (TTM):
$1.70
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $5.7B | $5.9B | $5.6B | $5.8B | |
| Revenue Growth (YoY) | 14.15% | 26.37% | 2.18% | -4.08% | 3.61% | |
| Cost of Revenues | $723.2M | $874.7M | $843.4M | $792.7M | $824.3M | |
| Gross Profit | $3.8B | $4.9B | $5B | $4.8B | $5B | |
| Gross Profit Margin | 84.08% | 84.76% | 85.62% | 85.91% | 85.86% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $28.5M | $29.9M | $30.8M | $32.7M | $20.5M | |
| Other Inc / (Exp) | -$32.6M | -$31.8M | -$35.7M | -$33.6M | -$36.1M | |
| Operating Expenses | $2.8B | $3.2B | $3.5B | $3.8B | $4.3B | |
| Operating Income | $992.7M | $1.7B | $1.5B | $1B | $750.2M | |
| Net Interest Expenses | $163.5M | $167.4M | $224M | $136.2M | $236.7M | |
| EBT. Incl. Unusual Items | $796.7M | $1.5B | $1.2B | $840.2M | $477.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $185.8M | $352.2M | $294.9M | $211.5M | $110.4M | |
| Net Income to Company | $610.9M | $1.1B | $924.5M | $628.7M | $367.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $610.9M | $1.1B | $924.5M | $628.7M | $367.1M | |
| Basic EPS (Cont. Ops) | $5.37 | $7.08 | $5.54 | $3.04 | $1.69 | |
| Diluted EPS (Cont. Ops) | $5.37 | $7.08 | $5.54 | $3.04 | $1.69 | |
| Weighted Average Basic Share | $196.1M | $196.1M | $196.1M | $196.1M | $196.1M | |
| Weighted Average Diluted Share | $196.1M | $196.1M | $196.1M | $196.1M | $196.1M | |
| EBITDA | $1.6B | $2.3B | $2.2B | $1.9B | $1.8B | |
| EBIT | $954.2M | $1.6B | $1.4B | $1.1B | $772M | |
| Revenue (Reported) | $4.5B | $5.7B | $5.9B | $5.6B | $5.8B | |
| Operating Income (Reported) | $992.7M | $1.7B | $1.5B | $1B | $750.2M | |
| Operating Income (Adjusted) | $954.2M | $1.6B | $1.4B | $1.1B | $772M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.2B | $1.1B | $1.2B | |
| Revenue Growth (YoY) | 29.01% | 13.06% | -0.81% | -7.8% | 12.55% | |
| Cost of Revenues | $177.6M | $195.9M | $175.7M | $166.6M | $179.5M | |
| Gross Profit | $882.3M | $1B | $1B | $929.4M | $1.1B | |
| Gross Profit Margin | 83.25% | 83.65% | 85.22% | 84.8% | 85.45% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.5M | $7.4M | $7.9M | $7.5M | $5.1M | |
| Other Inc / (Exp) | -$8.5M | -$9.4M | -$206.4M | -$146.8M | -$40.3M | |
| Operating Expenses | $742.7M | $836.8M | $696.8M | $824.7M | $1.1B | |
| Operating Income | $139.6M | $165.6M | $316.2M | $104.6M | -$2.9M | |
| Net Interest Expenses | $41.3M | $44.7M | $57.9M | -- | $71.4M | |
| EBT. Incl. Unusual Items | $89.8M | $111.5M | $51.9M | $13.7M | -$114.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $16M | $23.7M | $14.5M | $14.5M | -$32.2M | |
| Net Income to Company | $73.8M | $87.8M | $37.4M | -$863K | -$82.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $73.8M | $87.8M | $37.4M | -$863K | -$82.3M | |
| Basic EPS (Cont. Ops) | $2.63 | $0.44 | $0.16 | -$0.05 | -$0.46 | |
| Diluted EPS (Cont. Ops) | $2.63 | $0.44 | $0.16 | -$0.05 | -$0.46 | |
| Weighted Average Basic Share | $196.1M | $196.1M | $196.1M | $196.1M | $196.1M | |
| Weighted Average Diluted Share | $196.1M | $196.1M | $196.1M | $196.1M | $196.1M | |
| EBITDA | $298M | $332.5M | $321.3M | $304.1M | $220.7M | |
| EBIT | $129.8M | $154.8M | $109.2M | $77.9M | -$35M | |
| Revenue (Reported) | $1.1B | $1.2B | $1.2B | $1.1B | $1.2B | |
| Operating Income (Reported) | $139.6M | $165.6M | $316.2M | $104.6M | -$2.9M | |
| Operating Income (Adjusted) | $129.8M | $154.8M | $109.2M | $77.9M | -$35M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.5B | $5.7B | $5.9B | $5.6B | $5.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $723.2M | $874.7M | $843.4M | $792.7M | $824.3M | |
| Gross Profit | $3.8B | $4.9B | $5B | $4.8B | $5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $28.5M | $29.9M | $30.8M | $33M | $20.9M | |
| Other Inc / (Exp) | -$32.6M | -$31.8M | -$35.7M | -$33.2M | -$35.7M | |
| Operating Expenses | $2.8B | $3.2B | $3.5B | $3.8B | $4.3B | |
| Operating Income | $992.7M | $1.7B | $1.5B | $1B | $749.9M | |
| Net Interest Expenses | $163.5M | $167.4M | $224M | $136.2M | $236.7M | |
| EBT. Incl. Unusual Items | $796.7M | $1.5B | $1.2B | $840.2M | $477.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $185.8M | $352.2M | $294.9M | $211.5M | $110.4M | |
| Net Income to Company | $610.9M | $1.1B | $924.5M | $628.7M | $367.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $610.9M | $1.1B | $924.5M | $628.7M | $367.1M | |
| Basic EPS (Cont. Ops) | $5.37 | $6.18 | $5.55 | $3.04 | $1.70 | |
| Diluted EPS (Cont. Ops) | $5.37 | $6.18 | $5.55 | $3.04 | $1.70 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $1.6B | $2.3B | $2.2B | $1.9B | $1.8B | |
| EBIT | $954.2M | $1.6B | $1.4B | $1.1B | $772M | |
| Revenue (Reported) | $4.5B | $5.7B | $5.9B | $5.6B | $5.8B | |
| Operating Income (Reported) | $992.7M | $1.7B | $1.5B | $1B | $749.9M | |
| Operating Income (Adjusted) | $954.2M | $1.6B | $1.4B | $1.1B | $772M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.7B | $5.9B | $5.6B | $5.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $874.7M | $843.4M | $792.7M | $824.3M | -- | |
| Gross Profit | $4.9B | $5B | $4.8B | $5B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $29.9M | $30.8M | $33M | $20.9M | -- | |
| Other Inc / (Exp) | -$31.8M | -$35.7M | -$33.2M | -$35.7M | -- | |
| Operating Expenses | $3.2B | $3.5B | $3.8B | $4.3B | -- | |
| Operating Income | $1.7B | $1.5B | $1B | $749.9M | -- | |
| Net Interest Expenses | $167.4M | $224M | $192M | $236.7M | -- | |
| EBT. Incl. Unusual Items | $1.5B | $1.2B | $840.2M | $477.5M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $352.2M | $294.9M | $211.5M | $110.4M | -- | |
| Net Income to Company | $1.1B | $924.5M | $628.7M | $367.1M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $924.5M | $628.7M | $367.1M | -- | |
| Basic EPS (Cont. Ops) | $6.18 | $5.55 | $3.04 | $1.70 | -- | |
| Diluted EPS (Cont. Ops) | $6.18 | $5.55 | $3.04 | $1.70 | -- | |
| Weighted Average Basic Share | $784.3M | $784.3M | $784.3M | $784.3M | -- | |
| Weighted Average Diluted Share | $784.3M | $784.3M | $784.3M | $784.3M | -- | |
| EBITDA | $2.3B | $2.2B | $1.9B | $1.8B | -- | |
| EBIT | $1.6B | $1.4B | $1.1B | $772M | -- | |
| Revenue (Reported) | $5.7B | $5.9B | $5.6B | $5.8B | -- | |
| Operating Income (Reported) | $1.7B | $1.5B | $1B | $749.9M | -- | |
| Operating Income (Adjusted) | $1.6B | $1.4B | $1.1B | $772M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $2.7B | $2.1B | $1.5B | $988.8M | |
| Short Term Investments | $7.2M | $30.9M | $687.5M | $527.4M | $710.7M | |
| Accounts Receivable, Net | $218.6M | $231.6M | $187M | $210.4M | $231M | |
| Inventory | $105.6M | $158.9M | $151.5M | $150.9M | $163.1M | |
| Prepaid Expenses | $516.3M | $297.3M | $292.8M | $289.9M | $367.9M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2.1B | $3.5B | $3.4B | $2.8B | $2.5B | |
| Property Plant And Equipment | $9.3B | $10.3B | $11.9B | $13.5B | $15.3B | |
| Long-Term Investments | $3.1B | $3.3B | $2.7B | $2.6B | $2.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $567K | -- | -- | $67.9M | $41.3M | |
| Total Assets | $14.7B | $17.3B | $18.1B | $19.1B | $20.5B | |
| Accounts Payable | $645.6M | $677.8M | $235.9M | $240.1M | $263.3M | |
| Accrued Expenses | -- | -- | $525.1M | $543M | $557.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7B | $1.6B | $1.7B | $1.7B | $1.7B | |
| Long-Term Debt | $3.5B | $4.7B | $4.6B | $4.4B | $5.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.8B | $11.3B | $11.6B | $11.9B | $13B | |
| Common Stock | $10.5M | $10.5M | $10.7M | $10.7M | $10.7M | |
| Other Common Equity Adj | -$3.9M | -$444K | $4M | $6.3M | -$56K | |
| Common Equity | $4.9B | $6B | $6.5B | $7.2B | $7.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.9B | $6B | $6.5B | $7.2B | $7.5B | |
| Total Liabilities and Equity | $14.7B | $17.3B | $18.1B | $19.1B | $20.5B | |
| Cash and Short Terms | $1.2B | $2.7B | $2.7B | $2.1B | $1.7B | |
| Total Debt | $3.5B | $4.7B | $4.6B | $4.4B | $5.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.2B | $2.7B | $2.1B | $1.5B | $988.8M | |
| Short Term Investments | $7.2M | $30.9M | $687.5M | $527.4M | $710.7M | |
| Accounts Receivable, Net | $218.6M | $231.6M | $187M | $210.4M | $231M | |
| Inventory | $105.6M | $158.9M | $151.5M | $150.9M | $163.1M | |
| Prepaid Expenses | $516.3M | $297.3M | $292.8M | $289.9M | $367.9M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $2.1B | $3.5B | $3.4B | $2.8B | $2.5B | |
| Property Plant And Equipment | $9.3B | $10.3B | $11.9B | $13.5B | $15.3B | |
| Long-Term Investments | $3.1B | $3.3B | $2.7B | $2.6B | $2.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $567K | -- | -- | $67.9M | $41.3M | |
| Total Assets | $14.7B | $17.3B | $18.1B | $19.1B | $20.5B | |
| Accounts Payable | $645.6M | $677.8M | $235.9M | $240.1M | $263.3M | |
| Accrued Expenses | -- | -- | $525.1M | $543M | $557.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.7B | $1.6B | $1.7B | $1.7B | $1.7B | |
| Long-Term Debt | $3.5B | $4.7B | $4.6B | $4.4B | $5.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $9.8B | $11.3B | $11.6B | $11.9B | $13B | |
| Common Stock | $10.5M | $10.5M | $10.7M | $10.7M | $10.7M | |
| Other Common Equity Adj | -$3.9M | -$444K | $4M | $6.3M | -$56K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.9B | $6B | $6.5B | $7.2B | $7.5B | |
| Total Liabilities and Equity | $14.7B | $17.3B | $18.1B | $19.1B | $20.5B | |
| Cash and Short Terms | $1.2B | $2.7B | $2.7B | $2.1B | $1.7B | |
| Total Debt | $3.5B | $4.7B | $4.6B | $4.4B | $5.2B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $610.9M | $1.1B | $924.5M | $628.7M | $367.1M | |
| Depreciation & Amoritzation | $664M | $697M | $756.3M | $841.8M | $982.5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$40M | -$19.5M | $44.2M | -$38.6M | -$1.5M | |
| Change in Inventories | -$5.8M | -$53.3M | $7.3M | $518K | -$12.3M | |
| Cash From Operations | $1.5B | $1.9B | $1.7B | $1.5B | $1.5B | |
| Capital Expenditures | $1.4B | $2.1B | $2.7B | $3B | $3.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$1.9B | -$2.4B | -$2B | -$2.9B | |
| Dividends Paid (Ex Special Dividend) | -$49M | -$29.4M | -$33.7M | -$31.8M | -$35.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $922M | $2B | $1B | $1.2B | $1.9B | |
| Long-Term Debt Repaid | -$883.8M | -$603.8M | -$926.2M | -$1B | -$925.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $298.2M | $96.9M | $1.8M | -$62.7M | $705K | |
| Cash From Financing | $287.4M | $1.4B | $59.8M | $66.5M | $895.1M | |
| Beginning Cash (CF) | $494.4M | $1.2B | $2.7B | $2.1B | $1.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $693.2M | $1.5B | -$632M | -$527.1M | -$541.4M | |
| Ending Cash (CF) | $1.2B | $2.7B | $2.1B | $1.5B | $988.8M | |
| Levered Free Cash Flow | $93.9M | -$190.3M | -$994.3M | -$1.5B | -$2B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $345.2M | $338.3M | $256.8M | $195.4M | -- | |
| Depreciation & Amoritzation | $172M | $178.1M | $193.5M | $224.3M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$7.5M | $16.4M | -$14.3M | -$60.1M | -- | |
| Change in Inventories | -$15.8M | -$10.3M | -$13.4M | -$6.7M | -- | |
| Cash From Operations | $794.2M | $651.4M | $465.7M | $453.9M | -- | |
| Capital Expenditures | $508.4M | $646.1M | $773.6M | $963.2M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$523.2M | -$478M | -$288.7M | -$803.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$9.8M | -$7.1M | -$8.8M | -- | |
| Special Dividend Paid | $43.8K | $43.8K | -- | -- | -- | |
| Long-Term Debt Issued | $161.9M | $393.3M | $445.5M | $349.2M | -- | |
| Long-Term Debt Repaid | -$154.5M | -$180.4M | -$267M | -$340.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $49.1M | $21.8M | -$34.7M | -$30.9M | -- | |
| Cash From Financing | $56.4M | $224.9M | $136.7M | -$31.4M | -- | |
| Beginning Cash (CF) | $1.2B | $2.7B | $2.1B | $1.5B | -- | |
| Foreign Exchange Rate Adjustment | -$1.5M | -$4.1M | $2.8M | -$530K | -- | |
| Additions / Reductions | $327.5M | $398.3M | $313.8M | -$380.9M | -- | |
| Ending Cash (CF) | $1.5B | $3.1B | $2.4B | $1.2B | -- | |
| Levered Free Cash Flow | $285.8M | $5.2M | -$307.9M | -$509.3M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $610.9M | $1.1B | $924.5M | $628.7M | $367.1M | |
| Depreciation & Amoritzation | $664M | $697M | $756.3M | $841.8M | $982.5M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$40M | -$19.5M | $44.2M | -$38.6M | -$1.5M | |
| Change in Inventories | -$5.8M | -$53.3M | $7.3M | $518K | -$12.3M | |
| Cash From Operations | $1.5B | $1.9B | $1.7B | $1.5B | $1.5B | |
| Capital Expenditures | $1.4B | $2.1B | $2.7B | $3B | $3.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$1.9B | -$2.4B | -$2B | -$2.9B | |
| Dividends Paid (Ex Special Dividend) | -$49M | -$29.4M | -$33.7M | -$31.8M | -$35.3M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $922M | $2B | $1B | $1.2B | $1.9B | |
| Long-Term Debt Repaid | -$883.8M | -$603.8M | -$926.2M | -$1B | -$925.7M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $298.2M | $96.9M | $1.8M | -$62.7M | $705K | |
| Cash From Financing | $287.4M | $1.4B | $59.8M | $66.5M | $895.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $693.2M | $1.5B | -$632M | -$527.1M | -$541.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $93.9M | -$190.3M | -$994.3M | -$1.5B | -$2B | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $345.2M | $338.3M | $256.8M | $195.4M | -- | |
| Depreciation & Amoritzation | $172M | $178.1M | $193.5M | $224.3M | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$7.5M | $16.4M | -$14.3M | -$60.1M | -- | |
| Change in Inventories | -$15.8M | -$10.3M | -$13.4M | -$6.7M | -- | |
| Cash From Operations | $794.2M | $651.4M | $465.7M | $453.9M | -- | |
| Capital Expenditures | $508.4M | $646.1M | $773.6M | $963.2M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$523.2M | -$478M | -$288.7M | -$803.3M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -$9.8M | -$7.1M | -$8.8M | -- | |
| Special Dividend Paid | $43.8K | $43.8K | -- | -- | -- | |
| Long-Term Debt Issued | $161.9M | $393.3M | $445.5M | $349.2M | -- | |
| Long-Term Debt Repaid | -$154.5M | -$180.4M | -$267M | -$340.9M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $49.1M | $21.8M | -$34.7M | -$30.9M | -- | |
| Cash From Financing | $56.4M | $224.9M | $136.7M | -$31.4M | -- | |
| Beginning Cash (CF) | $1.2B | $2.7B | $2.1B | $1.5B | -- | |
| Foreign Exchange Rate Adjustment | -$1.5M | -$4.1M | $2.8M | -$530K | -- | |
| Additions / Reductions | $327.5M | $398.3M | $313.8M | -$380.9M | -- | |
| Ending Cash (CF) | $1.5B | $3.1B | $2.4B | $1.2B | -- | |
| Levered Free Cash Flow | $285.8M | $5.2M | -$307.9M | -$509.3M | -- | |
Get UHAL Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UHAL
Sector
P/E ratio
36.74x
18.58x
PEG ratio
--
0.25x
P/B ratio
1.57x
1.75x
Price / LTM sales
2.10x
0.94x
Growth Metrics
UHAL
Sector
Revenue growth
12.55%
1.98%
Earnings growth
-34.78%
2.46%
Revenue (5-year growth)
7.94%
4.35%
Earnings forecast
-$0.26
$0.40
Profitability
UHAL
Sector
Profitability FY 2024
$5B
$393.9M
Return on invested capital
3.01%
5.32%
Return on assets
1.85%
3.49%
Return on equity
4.94%
8.55%
Earnings Date
Last Earnings Date
May
28
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
27
Balance Sheet
UHAL
Sector
Total cash
$1.7B
$154.3M
Short term investments
$710.7M
$35.5M
Total assets
$20.5B
$1.7B
Long term debt
$5.2B
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
